Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "Cataract"

41 News Found

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
Drug Approval | June 01, 2022

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children


ASG Eye Hospitals opens unit in Dombivli, Maharashtra
Hospitals | May 26, 2022

ASG Eye Hospitals opens unit in Dombivli, Maharashtra

The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra


50% of the world's population expected to be myopic by 2050
News | May 23, 2022

50% of the world's population expected to be myopic by 2050

Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear


ZEISS announces USFDA clearance of the Quatera 700
Digitisation | April 21, 2022

ZEISS announces USFDA clearance of the Quatera 700

The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise


Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals
interviews | March 10, 2022

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals

As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma


Experts point out key issues for vision loss at ASSOCHAM meet
Healthcare | February 24, 2022

Experts point out key issues for vision loss at ASSOCHAM meet

Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes


Ophthalmologists converge in Chennai to discuss latest innovations
Events | December 05, 2021

Ophthalmologists converge in Chennai to discuss latest innovations

IIRSI 2021 aims to bring together ophthalmologists across India and abroad to discuss the advancement in technology and their experience in IOL implantation and Refractive Surgery


Amneal gets approval for Difluprednate ophthalmic emulsion
Drug Approval | November 22, 2021

Amneal gets approval for Difluprednate ophthalmic emulsion

The company is moving towards complex and more differentiated products


Alcon announces launch of AcrySof IQ Vivity in India,
Medical Device | October 19, 2021

Alcon announces launch of AcrySof IQ Vivity in India,

It is the first presbyopia-correcting lens implant for cataract surgery


ENTOD Pharma launches surgical division HyTek
Medical Device | September 14, 2021

ENTOD Pharma launches surgical division HyTek

The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others